The Claim
Blood levels of neurofilament light chain increase 9 to 10 years prior to the clinical diagnosis of Alzheimer's disease, reflecting ongoing neurodegeneration.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Blood levels of neurofilament light chain rise 9 to 10 years before a person is diagnosed with Alzheimer's disease, indicating that nerve cell damage is already occurring.
See the scientific wording
Neurofilament light chain levels in blood rise 9 to 10 years before clinical onset of Alzheimer's disease, indicating active neurodegeneration.
When nerve cells in the brain start to break down, their internal scaffolding called neurofilament light chain leaks out. This protein first shows up in the fluid surrounding the brain and spinal cord. Over time, as the barrier that normally keeps brain fluids separate from the blood weakens, more of this protein escapes into the bloodstream, where it can be measured years before symptoms appear.
What the research says
1 studyThis study found that a protein in the blood called NfL starts rising about 19 years before people show signs of Alzheimer’s, meaning brain damage is already happening long before symptoms appear — which supports the idea that this blood test can detect the disease early.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.